Conference Abstract

Utilization, User Characteristics, and Adverse Outcomes of Insulin Glargine Originators and Follow-on Drug in Patients with Diabetes in the US

38th Annual International Society for Pharmacoepidemiology Conference
August 1, 2022
Authors:

Rai A, Nam YH, Mendelsohn AB, Marshall J, McDermott CL, Toh S, Lockhart CM

Expertise:
RWE Research & Consulting
View the Poster

Rai A, Nam YH, Mendelsohn AB, Marshall J, McDermott CL, Toh S, Lockhart CM. Utilization, User Characteristics, and Adverse Outcomes of Insulin Glargine Originators and Follow-on Drug in Patients with Diabetes in the US. 38th Annual International Society for Pharmacoepidemiology Conference; 2022 Aug 1; Copenhagen, Denmark.